DBV Technologies (DBVT) Cash from Investing Activities Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -122.45% |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | 25.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.00% |
| Dec 31, 2025 | -190.16% |
| Sep 30, 2025 | -121.10% |
| Jun 30, 2025 | -101.88% |
| Mar 31, 2025 | 81.24% |
| Dec 31, 2024 | 524.06% |
| Sep 30, 2024 | 66.15% |
| Jun 30, 2024 | 302.64% |
| Mar 31, 2024 | -5,176.19% |
| Dec 31, 2023 | -450.00% |
| Sep 30, 2023 | -311.84% |
| Jun 30, 2023 | -48.91% |
| Mar 31, 2023 | 281.82% |
| Dec 31, 2022 | 92.83% |
| Sep 30, 2022 | 181.48% |
| Jun 30, 2022 | -233.14% |
| Mar 31, 2022 | 105.95% |
| Dec 31, 2021 | 25.12% |
| Sep 30, 2021 | 106.91% |
| Jun 30, 2021 | 133.08% |
| Mar 31, 2021 | 80.11% |
| Dec 31, 2018 | -6.93% |
| Dec 31, 2017 | -2.93% |